Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa
- PMID: 6207771
- PMCID: PMC284130
- DOI: 10.1128/AAC.26.2.250
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa
Abstract
Clinical isolates of Pseudomonas aeruginosa were examined for the basis of impermeability-type aminoglycoside resistance. Two apparently related burn isolate strains with high-level (strain 8803) and low-level (strain 13934) gentamicin resistance each had a plasmid. Transformation of the plasmid from either strain to P. aeruginosa PAO503 resulted in low-level gentamicin resistance. No mechanism for this resistance could be determined. Low-level gentamicin and streptomycin resistance from strain 8803 (but not 13934) was transduced with phage E79.tv2 to PAO503 without transfer of plasmid DNA. Transductants like strain 8803 showed absence or reduction of the lipopolysaccharide (LPS) "ladder" pattern of PAO503, had a change in chemical composition of LPS, and, like strain 8803, had a reduced capability to accumulate streptomycin. Comparison of the resistant clinical isolates 8803 and P10 with the apparently related but less-resistant strains 13934 and P10R, respectively, showed the latter strains had LPS ladder patterns and the former strains did not. Strain 8803 had normal outer membrane protein profiles, electron transport components, and transmembrane electrical potential relative to PAO503 and has been previously shown to have no detectable gentamicin-modifying enzymes and normal protein synthesis. We conclude that low-level impermeability-type aminoglycoside resistance in P. aeruginosa results from conversion of smooth LPS to superficial or deeper rough LPS phenotypes. High-level resistance apparently results from a plasmid-specified, but as yet unknown, mechanism combined with the preceding change in LPS structure.
Similar articles
-
Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase.Antimicrob Agents Chemother. 1980 Jan;17(1):71-9. doi: 10.1128/AAC.17.1.71. Antimicrob Agents Chemother. 1980. PMID: 6243453 Free PMC article.
-
Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients.Indian J Med Res. 2005 Oct;122(4):324-9. Indian J Med Res. 2005. PMID: 16394325
-
Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.Am J Clin Pathol. 1984 Jun;81(6):742-7. doi: 10.1093/ajcp/81.6.742. Am J Clin Pathol. 1984. PMID: 6428216
-
Aminoglycoside resistance in Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2005 Feb;49(2):479-87. doi: 10.1128/AAC.49.2.479-487.2005. Antimicrob Agents Chemother. 2005. PMID: 15673721 Free PMC article. Review. No abstract available.
-
Review of epidemic aminoglycoside resistance worldwide.Am J Med. 1986 Jun 30;80(6B):56-64. doi: 10.1016/0002-9343(86)90480-8. Am J Med. 1986. PMID: 3089005 Review.
Cited by
-
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1986 Mar;29(3):445-50. doi: 10.1128/AAC.29.3.445. Antimicrob Agents Chemother. 1986. PMID: 3087283 Free PMC article.
-
Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.Antimicrob Agents Chemother. 1988 Nov;32(11):1636-9. doi: 10.1128/AAC.32.11.1636. Antimicrob Agents Chemother. 1988. PMID: 2855296 Free PMC article.
-
Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy.PLoS One. 2011;6(12):e28831. doi: 10.1371/journal.pone.0028831. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22216120 Free PMC article.
-
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1989 Nov;33(11):1921-6. doi: 10.1128/AAC.33.11.1921. Antimicrob Agents Chemother. 1989. PMID: 2514623 Free PMC article.
-
The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence.Sci Rep. 2017 Nov 24;7(1):16302. doi: 10.1038/s41598-017-16411-4. Sci Rep. 2017. PMID: 29176754 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical